- Home
- BFIN vs PROK Comparison
BFIN vs PROK Comparison
Compare BFIN & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BFIN
- PROK
- Stock Information
- Founded
- BFIN 1924
- PROK 2015
- Country
- BFIN United States
- PROK United States
- Employees
- BFIN N/A
- PROK N/A
- Industry
- BFIN Savings Institutions
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BFIN Finance
- PROK Health Care
- Exchange
- BFIN Nasdaq
- PROK Nasdaq
- Market Cap
- BFIN 164.7M
- PROK 186.8M
- IPO Year
- BFIN N/A
- PROK N/A
- Fundamental
- Price
- BFIN $12.66
- PROK $0.95
- Analyst Decision
- BFIN
- PROK Buy
- Analyst Count
- BFIN 0
- PROK 4
- Target Price
- BFIN N/A
- PROK $5.00
- AVG Volume (30 Days)
- BFIN 13.7K
- PROK 530.0K
- Earning Date
- BFIN 05-08-2025
- PROK 05-09-2025
- Dividend Yield
- BFIN 3.17%
- PROK N/A
- EPS Growth
- BFIN N/A
- PROK N/A
- EPS
- BFIN 0.33
- PROK N/A
- Revenue
- BFIN $49,205,000.00
- PROK N/A
- Revenue This Year
- BFIN $2.15
- PROK N/A
- Revenue Next Year
- BFIN $8.53
- PROK N/A
- P/E Ratio
- BFIN $38.18
- PROK N/A
- Revenue Growth
- BFIN N/A
- PROK N/A
- 52 Week Low
- BFIN $9.60
- PROK $0.94
- 52 Week High
- BFIN $13.97
- PROK $4.44
- Technical
- Relative Strength Index (RSI)
- BFIN 46.36
- PROK 25.06
- Support Level
- BFIN $12.28
- PROK $0.94
- Resistance Level
- BFIN $13.04
- PROK $1.08
- Average True Range (ATR)
- BFIN 0.38
- PROK 0.11
- MACD
- BFIN -0.05
- PROK -0.02
- Stochastic Oscillator
- BFIN 29.23
- PROK 2.15
About BFIN BankFinancial Corporation
BankFinancial Corp is a national bank principally engaged in the business of commercial, family and personal banking. It offers customers a broad range of loan, deposit, trust and other financial products and services. The Bank offers customers a broad range of loan, deposit, trust and other financial products and services through all full-service banking offices located in Cook, DuPage, Lake and Will Counties, Illinois and through Internet Branch.
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of development program for severe diabetic kidney disease.